as a result of the issuance of the Non-Redemption Bonus Shares. As a result, the Sponsors will forfeit the number of Private Warrants such that the number of TradeStation Shares issuable upon exercise of the Private Warrants following the Merger shall equal the number of Quantum Shares for which the Private Warrants were exercisable prior to the Merger.
Results of Operations
Quantum has neither engaged in any operations nor generated any revenues to date. Quantum’s only activities through March 31, 2022 were formation, the IPO and, subsequent to the IPO, identifying a target company for a business combination. Quantum does not expect to generate any operating revenues until after the completion of its business combination. Quantum generates non-operating income in the form of interest income on marketable securities held in the Trust Account. Quantum incurs expenses as a result of being a public company (for legal, financial reporting, accounting and auditing compliance), as well as for due diligence expenses.
For the three months ended March 31, 2022, Quantum had a net income of $1,356,947, which consists of interest earned on marketable securities held in the Trust Account of $20,999, change in fair value of PIPE derivative liability of $1,366,000 and change in fair value of warrant liability of $658,842, partially offset by operating costs of $688,894.
For the three months ended March 31, 2021, Quantum had a net income of $1,742,262, which consists of an unrealized gain on marketable securities held in the Trust Account of $10,785, change in fair value of warrant liability of $1,969,000, partially offset by operating costs of $237,523.
For the year ended December 31, 2021, Quantum had a net loss of $5,702,793, which consists of a change in fair value of the PIPE derivative liability of $966,000, unrealized gain on marketable securities held in the Trust Account of $2,395, and interest earned on marketable securities held in the Trust Account of $56,233, offset by operating costs of $3,404,429 and change in fair value of warrant liability of $3,322,992.
For the period from October 1, 2020 (inception) through December 31, 2020, Quantum had a net loss of $5,420, which consisted of formation and operation costs.
Liquidity and Capital Resources
On February 9, 2021, Quantum consummated the IPO of 17,500,000 Quantum Units at a price of $10.00 per Quantum Unit, each Quantum Unit consisting of Quantum Share, par value $0.0001 per share, and one warrant to purchase one-half of one Quantum Share at an exercise price of $11.50, generating gross proceeds of $175,000,000. Simultaneously with the closing of the IPO, Quantum consummated the sale of 5,562,500 Private Warrants at a price of $1.00 per Private Warrant in a private placement to Chardan and Sponsor Holdco, generating gross proceeds of $5,562,500.
On February 12, 2021, in connection with the underwriters’ exercise of their over-allotment option in full, Quantum consummated the sale of an additional 2,625,000 Quantum Units at a price of $10.00 per Quantum Unit, generating total gross proceeds of $26,250,000. In addition, Quantum consummated the sale of an additional 590,625 Private Warrants at $1.00 per Private Warrant, generating gross proceeds of $590,625.
Following the IPO (including the full exercise of the over-allotment option) and the sale of the Private Warrants, a total of $201,250,000 was placed in the Trust Account. Quantum incurred $5,017,526 in IPO related costs, including $4,528,125 of underwriting fees and $489,401 of other costs.
For the three months ended March 31, 2022, cash used in operating activities was $245,676. Net income of $1,356,947 was affected by interest earned on marketable securities held in the Trust Account of $20,999, change in fair value of PIPE derivative liability of $1,366,000 and the change in fair value of warrant liability of $658,842. Changes in operating assets and liabilities provided $443,218 of cash for operating activities.
For the three months ended March 31, 2021, cash used in operating activities was $687,775. Net income of $1,742,262 was affected by unrealized gain on marketable securities held in the Trust Account of